SCHEMBL27889652

SCHEMBL27889652

Nc1cc(C(F)(F)F)cnc1CC(=O)O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGBL2 Q5U5Z8 2/20 0.69
CFTR P13569 1/20 0.45
GLA P06280 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
POLQ O75417 1/20 0.44
ALDH1A1 P00352 2/20 0.42
HPGD P15428 2/20 0.42
KDM4E B2RXH2 1/20 0.42
HSD17B10 Q99714 1/20 0.42
HTT P42858 1/20 0.40
RAB9A P51151 1/20 0.40
MDM2 Q00987 1/20 0.40
RXRA P19793 1/20 0.40
RXRB P28702 1/20 0.40
RXRG P48443 1/20 0.40
KMT2A Q03164 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29135531 0.82 AGBL2 (0.71) AGBL2GLASMN1; SMN2POLQALDH1A1
SCHEMBL30716956 0.82 AGBL2 (0.71) AGBL2GLASMN1; SMN2POLQALDH1A1
SCHEMBL12698841 0.82 AGBL2 (1.00) AGBL2GLASMN1; SMN2POLQALDH1A1
SCHEMBL27716277 0.81 AGBL2 (0.69) AGBL2GLASMN1; SMN2ALDH1A1HPGD
Water SCHEMBL31648404 0.78 AGBL2 (0.66) AGBL2GLASMN1; SMN2POLQALDH1A1
SCHEMBL27956188 0.75 AGBL2 (0.44) AGBL2GLAALDH1A1KDM4EHSD17B10
SCHEMBL2373055 0.75 CFTR (0.55) AGBL2CFTRGLASMN1; SMN2ALDH1A1
SCHEMBL21433001 0.73 AGBL2 (0.44) AGBL2CFTRSMN1; SMN2POLQALDH1A1
SCHEMBL28813259 0.72 L3MBTL1 (0.40) AGBL2CFTRSMN1; SMN2ALDH1A1HPGD
SCHEMBL27305171 0.72 KMT2A (0.40) AGBL2CFTRSMN1; SMN2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103946221-A Heterocyclic compounds for the treatment of cystic fibrosis NOVARTIS AG 2014-07-23 CN disclosed
CN-102892758-A Pyridine and pyrazine derivatives for the treatment of CF NOVARTIS AG 2013-01-23 CN disclosed